Arbutus Biopharma Corp. (ABUS)
4.22
+0.04
(+0.96%)
USD |
NASDAQ |
Oct 09, 16:00
4.21
-0.01
(-0.24%)
Pre-Market: 20:00
Arbutus Biopharma Free Cash Flow : -24.13M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.13M |
| March 31, 2026 | -34.44M |
| December 31, 2025 | -39.72M |
| September 30, 2025 | -44.71M |
| June 30, 2025 | -59.64M |
| March 31, 2025 | -57.64M |
| December 31, 2024 | -63.64M |
| September 30, 2024 | -70.63M |
| June 30, 2024 | -71.81M |
| March 31, 2024 | -78.13M |
| December 31, 2023 | -86.16M |
| September 30, 2023 | -85.93M |
| June 30, 2023 | -82.44M |
| March 31, 2023 | -82.36M |
| December 31, 2022 | -34.39M |
| September 30, 2022 | -37.92M |
| June 30, 2022 | -34.80M |
| March 31, 2022 | -29.44M |
| December 31, 2021 | -67.97M |
| September 30, 2021 | -64.65M |
| June 30, 2021 | -62.35M |
| March 31, 2021 | -55.71M |
| December 31, 2020 | -53.19M |
| September 30, 2020 | -50.34M |
| June 30, 2020 | -61.59M |
| Date | Value |
|---|---|
| March 31, 2020 | -70.81M |
| December 31, 2019 | -71.97M |
| September 30, 2019 | -75.44M |
| June 30, 2019 | -64.19M |
| March 31, 2019 | -64.12M |
| December 31, 2018 | -67.72M |
| September 30, 2018 | -60.58M |
| June 30, 2018 | -66.03M |
| March 31, 2018 | -56.34M |
| December 31, 2017 | -57.08M |
| September 30, 2017 | -63.62M |
| June 30, 2017 | -59.83M |
| March 31, 2017 | -70.58M |
| December 31, 2016 | -61.44M |
| September 30, 2016 | -62.40M |
| June 30, 2016 | -48.89M |
| March 31, 2016 | -48.52M |
| December 31, 2015 | -54.68M |
| September 30, 2015 | -44.29M |
| June 30, 2015 | -50.01M |
| March 31, 2015 | -39.91M |
| December 31, 2014 | -13.11M |
| September 30, 2014 | -3.902M |
| June 30, 2014 | -0.6527M |
| March 31, 2014 | 4.576M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -837.67M |
| Pfizer Inc. | 10.99B |
| Gossamer Bio, Inc. | -164.59M |
| Legend Biotech Corp. | -264.16M |
| Moderna, Inc. | -1.244B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.952M |
| Cash from Investing (Quarterly) | -1.664M |
| Cash from Financing (Quarterly) | 3.079M |
| Free Cash Flow Per Share (Quarterly) | -0.0301 |
| Free Cash Flow to Equity (Quarterly) | -5.668M |
| Free Cash Flow to Firm (Quarterly) | -5.934M |
| Free Cash Flow Yield | -2.94% |